{"id":"NCT02520388","sponsor":"Ironshore Pharmaceuticals and Development, Inc","briefTitle":"A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting","officialTitle":"Ph 3 Multicenter DBRCT Parallel Group Study to Evaluate Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & Extended Release Formulation (DELEXIS) of MPH HCl, on Post-waking, Early Morning Function in Children Aged 6-12 With ADHD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08","primaryCompletion":"2016-04","completion":"2016-05","firstPosted":"2015-08-11","resultsPosted":"2018-10-03","lastUpdate":"2021-07-23"},"enrollment":163,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"HLD200 methylphenidate hydrochloride (MPH) Capsules","otherNames":["methylphenidate"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"HLD200 (methylphenidate)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 pivotal efficacy trial will examine the effects of HLD200 (methylphenidate) in patients aged 6-12 years with ADHD in a naturalistic setting. Following a screening/washout period (Visit 1), subjects will randomized to double-blind placebo or HLD200 for a period of 3 weeks (Visits 2-5) before assessing clinical study endpoints at last study visit.","primaryOutcome":{"measure":"Attention Deficit Hyperactivity Disorder Rating Scale Based on DSM-IV Criteria (ADHD-RS-IV) Total Score.","timeFrame":"Last week of 3-week treatment period assessed at Visit 5.","effectByArm":[{"arm":"HLD200 (Methylphenidate)","deltaMin":24.1,"sd":1.5},{"arm":"Placebo","deltaMin":31.2,"sd":1.6}],"pValues":[{"comp":"OG000 vs OG001","p":"0.05"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":21,"countries":["United States"]},"refs":{"pmids":["36971690","34085581","33797983"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":81},"commonTop":["Any Insomnia","Decreased appetite","Headache","Vomiting","Affect lability/mood swings"]}}